(Q37851321)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Interleukin-6-174 G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

0 references

Chlamydia pneumoniae

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Taina Lajunen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

R Juvonen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M Paldanius

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

S Silvennoinen-Kassinen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

A Peitso

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

O Vainio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M Leinonen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

P Saikku

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

1 reference

1 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

95-99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21352255%20AND%20SRC:MED&resulttype=core&format=json

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Adipocyte, adipose tissue, and infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Clinical value of blocking IL-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Evidence for infectious agents in cardiovascular disease and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Epidemiology of Chlamydia pneumoniae in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Induction of macrophage foam cell formation by Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Chlamydia pneumoniae infection is associated with elevated body mass index in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

The link between abdominal obesity, metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Chlamydia pneumoniae burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Chlamydia pneumoniae IgG antibody prevalence in south-western and eastern Finland in 1982 and 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Asthmatic persons are prone to the persistence of Chlamydia pneumoniae antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X

Increased aortic intima-media thickness in 11-year-old healthy children with persistent Chlamydia pneumoniae seropositivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02542.X